HuagongsheHuagongshe Chemistry Print Report · For research reference only
N-(1-Cyano-piperidin-4-yl)-N-cyclopropyl-4-oxazol-5-yl-benzamide → N-Cyclopropyl-4-oxazol-5-yl-N-{1-[3-(3,3,3-trifluoro-propyl)-[1,2,4]oxadiazol-5-yl]-piperidin-4-yl}-benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | N-(1-Cyano-piperidin-4-yl)-N-cyclopropyl-4-oxazol-5-yl-benzamide | HCID 86678209 | — |
| Reactant | HCID 178511022 | HCID 178511022 | — |
| Product | N-Cyclopropyl-4-oxazol-5-yl-N-{1-[3-(3,3,3-trifluoro-propyl)-[1,2,4]oxadiazol-5-yl]-piperidin-4-yl}-benzamide | HCID 68351875 | — |
Reaction Steps
The title compound is prepared from N-(1-cyano-piperidin-4-yl)-N-cyclopropyl-4-oxazol-5-yl-benzamide and 4,4,4-trifluoro-N-hydroxy-butyramidine following a procedure analogous to that described in Example 1. LC (method 8): tR=1.30 min; Mass spectrum (ESI+): m/z=476 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08822471B2 |
| Source dataset | uspto-grants-2014_09 |
| ORD ID | ord-1d0611f1a4e9406888cd163f1ddeca8f |
| Source note | uspto-grants-2014_09 |